(PLUS) ePlus - Overview
Sector: Technology | Industry: Software - Application | Exchange: NASDAQ (USA) | Market Cap: 2.257m USD | Total Return: 25.1% in 12m
Industry Rotation: +9.1
Avg Turnover: 14.2M
EPS Trend: 27.7%
Qual. Beats: 2
Rev. Trend: 52.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
ePlus inc. (NASDAQ: PLUS) is an information technology solutions provider that integrates third-party hardware, software, and cloud services for a diverse client base, including healthcare, government, and financial services sectors. The company operates through two primary segments: Technology and Financing. The Technology segment focuses on security, cloud consulting, and AI advisory, while the Financing segment manages the lifecycle of IT assets through leasing and disposal services.
As a technology distributor and value-added reseller (VAR), ePlus earns margins by bundling complex professional services with hardware and software procurement. This business model benefits from the increasing complexity of hybrid cloud environments, which forces organizations to outsource infrastructure management to specialized third parties. Technology distributors typically operate with high inventory turnover and rely on strategic partnerships with major original equipment manufacturers (OEMs).
Investors can further evaluate these operational segments and historical performance trends by reviewing the detailed data on ValueRay. ePlus continues to expand its geographic footprint and service offerings, recently emphasizing managed security and sustainable infrastructure solutions like EV charging and asset recovery.
- Shift toward high-margin managed services and security software improves overall gross margins
- Enterprise IT spending cycles drive hardware and software license revenue fluctuations
- Expansion of AI advisory and cloud consulting services captures digital transformation budgets
- Rising interest rates impact financing segment profitability and customer equipment leasing demand
- Public sector and healthcare contract wins provide stable long-term recurring revenue streams
| Net Income: 132.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA -17.19 > 1.0 |
| NWC/Revenue: 32.73% < 20% (prev 24.44%; Δ 8.29% < -1%) |
| CFO/TA -0.03 > 3% & CFO -60.2m > Net Income 132.8m |
| Net Debt (-193.1m) to EBITDA (204.9m): -0.94 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.3m) vs 12m ago -1.25% < -2% |
| Gross Margin: 25.58% > 18% (prev 0.25%; Δ 2.53k% > 0.5%) |
| Asset Turnover: 131.1% > 50% (prev 118.6%; Δ 12.54% > 0%) |
| Interest Coverage Ratio: 306.0 > 6 (EBITDA TTM 204.9m / Interest Expense TTM 572k) |
| A: 0.42 (Total Current Assets 1.45b - Total Current Liabilities 682.1m) / Total Assets 1.83b |
| B: 0.52 (Retained Earnings 945.3m / Total Assets 1.83b) |
| C: 0.10 (EBIT TTM 175.0m / Avg Total Assets 1.80b) |
| D: 1.24 (Book Value of Equity 951.1m / Total Liabilities 768.4m) |
| Altman-Z'' Score: 6.40 = AAA |
| DSRI: 0.82 (Receivables 741.5m/805.2m, Revenue 2.36b/2.09b) |
| GMI: 0.96 (GM 25.58% / 24.68%) |
| AQI: 0.59 (AQ_t 0.15 / AQ_t-1 0.26) |
| SGI: 1.13 (Revenue 2.36b / 2.09b) |
| TATA: 0.11 (NI 132.8m - CFO -60.2m) / TA 1.83b) |
| Beneish M-Score: -3.25 (Cap -4..+1) = AA |
Over the past week, the price has changed by -2.78%, over one month by -4.49%, over three months by -0.68% and over the past year by +25.13%.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 115 | 40.3% |
P/E Forward = 16.4474
P/S = 0.9375
P/B = 2.2444
P/EG = 0.9133
Revenue TTM = 2.36b USD
EBIT TTM = 175.0m USD
EBITDA TTM = 204.9m USD
Long Term Debt = 11.3m USD (from longTermDebt, last fiscal year)
Short Term Debt = 133.2m USD (from shortTermDebt, last quarter)
Debt = 133.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -193.1m USD (from netDebt column, last quarter)
Enterprise Value = 2.06b USD (2.26b + Debt 133.2m - CCE 326.3m)
Interest Coverage Ratio = 306.0 (Ebit TTM 175.0m / Interest Expense TTM 572k)
EV/FCF = -31.58x (Enterprise Value 2.06b / FCF TTM -65.3m)
FCF Yield = -3.17% (FCF TTM -65.3m / Enterprise Value 2.06b)
FCF Margin = -2.77% (FCF TTM -65.3m / Revenue TTM 2.36b)
Net Margin = 5.63% (Net Income TTM 132.8m / Revenue TTM 2.36b)
Gross Margin = 25.58% ((Revenue TTM 2.36b - Cost of Revenue TTM 1.76b) / Revenue TTM)
Gross Margin QoQ = 24.75% (prev 26.63%)
Tobins Q-Ratio = 1.13 (Enterprise Value 2.06b / Total Assets 1.83b)
Interest Expense / Debt = 0.43% (Interest Expense 572k / Debt 133.2m)
Taxrate = 26.74% (12.2m / 45.6m)
NOPAT = 128.2m (EBIT 175.0m * (1 - 26.74%))
Current Ratio = 2.13 (Total Current Assets 1.45b / Total Current Liabilities 682.1m)
Debt / Equity = 0.13 (Debt 133.2m / totalStockholderEquity, last quarter 1.06b)
Debt / EBITDA = -0.94 (Net Debt -193.1m / EBITDA 204.9m)
Debt / FCF = 2.96 (negative FCF - burning cash) (Net Debt -193.1m / FCF TTM -65.3m)
Total Stockholder Equity = 1.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.38% (Net Income 132.8m / Total Assets 1.83b)
RoE = 12.93% (Net Income TTM 132.8m / Total Stockholder Equity 1.03b)
RoCE = 16.86% (EBIT 175.0m / Capital Employed (Equity 1.03b + L.T.Debt 11.3m))
RoIC = 11.16% (NOPAT 128.2m / Invested Capital 1.15b)
WACC = 8.65% (E(2.26b)/V(2.39b) * Re(9.14%) + D(133.2m)/V(2.39b) * Rd(0.43%) * (1-Tc(0.27)))
Discount Rate = 9.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -71.91 | Cagr: -0.65%
[DCF] Fair Price = unknown (Cash Flow -65.3m)
EPS Correlation: 27.69 | EPS CAGR: 10.12% | SUE: 2.00 | # QB: 2
Revenue Correlation: 52.93 | Revenue CAGR: 8.58% | SUE: 0.83 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.27 | Chg30d=-0.78% | Revisions=-20% | Analysts=2
[Analyst] Revisions Ratio: -20%